Skip to main content
. Author manuscript; available in PMC: 2020 May 1.
Published in final edited form as: Biochim Biophys Acta Mol Basis Dis. 2018 Sep 3;1865(5):1031–1039. doi: 10.1016/j.bbadis.2018.08.037

Table 3.

Major animal models of idiosyncratic drug-induced liver injury

Model Strategy Strengths Weaknesses
Inflammagen model LPS co-administration Easy to use Poor resemblance to human IDILI
Uetrecht-Pohl model Compromised immune tolerance Time course and pathology resemble human IDILI No liver failure
Subclinical mitochondriopathy Compromised ROS defense Time course resembles human IDILI Poor reproducibility